日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model

高纤维植物性饮食对骨髓瘤前驱疾病的影响:来自 NUTRIVENTION 临床试验和临床前 Vk*MYC 模型的结果

Shah, Urvi A; Cogrossi, Laura Lucia; Garcés, Juan-Jose; Policastro, Anna; Castro, Francesca; Derkach, Andriy; Fei, Teng; DeWolf, Susan; Grioni, Matteo; Sisti, Sofia; Blaslov, Jenna; Adintori, Peter A; Hosszu, Kinga K; McAvoy, Devin; Baichoo, Mirae; Cross, Justin R; Paredes, Jenny; Anuraj, Aishwarya; Raj, Sandeep S; Pohl, Charlotte; Zordan, Paola; Zinsmeyer, Victoria; Jesus Faustino Ramos, Ruben J; Lorenzoni, Marco; Gipson, Brianna; Maclachlan, Kylee H; Gradissimo, Ana; Boiocchi, Leonardo; Aleynick, Nathan; Marchigiani, Camilla; Pagani, Sara; Salehi, Erica; Koche, Richard P; Chaligne, Ronan; Block, Torin; Korde, Neha; Tan, Carlyn R; Hultcrantz, Malin; Hassoun, Hani; Shah, Gunjan L; Scordo, Michael; Lahoud, Oscar B; Chung, David J; Landau, Heather J; Peled, Jonathan U; Clementi, Nicola; Chesi, Marta; Bergsagel, P Leif; Mailankody, Sham; Pollak, Michael N; D'Souza, Anita; Landgren, Ola; Chimonas, Susan; Giralt, Sergio A; Usmani, Saad Z; Iyengar, Neil M; Lesokhin, Alexander M; van den Brink, Marcel R M; Bellone, Matteo

Atrial Fibrillation Following Autologous Stem Cell Transplantation in Multiple Myeloma: Incidence, Predictors, and Prognostic Impact

多发性骨髓瘤自体干细胞移植后房颤:发生率、预测因素和预后影响

Bolaji, Olayiwola; Brown, Samantha; Shaffer, Brian C; Heller, Glenn; Beaulieu, Marie-Claude; Ip, James E; Chen, Carol L; Giralt, Sergio; Kosmidou, Ioanna; Landau, Heather J; Saad, Usmani; Scordo, Michael; Shah, Gunjan; Shouval, Roni; Yu, Anthony F; Liu, Jennifer E

IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM

IMS-IMWG 2025共识基因组分期可预测基于达雷妥尤单抗的四联疗法治疗新诊断多发性骨髓瘤的疗效。

Maclachlan, Kylee H; Tan, Carlyn R; Shekarkhand, Tala; Rueda, Colin; Derkach, Andriy; Hashmi, Hamza; Hassoun, Hani; Shah, Urvi A; Hultcrantz, Malin; Lesokhin, Alexander M; Mailankody, Sham; Maura, Francesco; Merz, Maximillian; Firestone, Ross; Jurgens, Eric M; Miller, Kevin C; Rajeeve, Sridevi; Giralt, Sergio; Shah, Gunjan L; Scordo, Michael; Landau, Heather J; Zhang, Yanming; Cimera, Robert; Arcila, Maria E; Korde, Neha; Usmani, Saad Z

Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United States

美国肾移植候选者和接受者浆细胞疾病的临床管理模式

Boppana, Samhita; Blosser, Christopher D; Webber, Allison B; Gupta, Gaurav; Singh, Neeraj; Master, Samip; Parasuraman, Raviprasenna; Campagnaro, Erica L; Java, Anuja; Sprangers, Ben; Bhasin-Chhabra, Bhavna; Lum, Erik L; Khirfan, Diala; Alexander, Mariam; Leung, Nelson; Landau, Heather; Murakami, Naoka

Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis

MCARH109(一种靶向G蛋白偶联受体C类5成员D (GPRC5D) 的嵌合抗原受体T细胞疗法)治疗多发性骨髓瘤的I期临床试验:最新分析

Jurgens, Eric M; Firestone, Ross S; Chaudhari, Jagrutiben; Hosszu, Kinga; Devlin, Sean M; Shah, Urvi A; Landa, Jonathan; McAvoy, Devin P; Lesokhin, Alexander M; Korde, Neha; Hassoun, Hani; Tan, Carlyn R; Hultcrantz, Malin; Shah, Gunjan L; Landau, Heather J; Chung, David J; Scordo, Michael; Eren, Ozgur Can; Dogan, Ahmet; Giralt, Sergio A; Park, Jae H; Rivière, Isabelle; Brentjens, Renier J; Smith, Eric L; Wang, Xiuyan; Usmani, Saad Z; Mailankody, Sham

Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma

复发/难治性多发性骨髓瘤的标准治疗方案idecabtagene vicleucel

Sidana, Surbhi; Ahmed, Nausheen; Akhtar, Othman Salim; Brazauskas, Ruta; Oloyede, Temitope; Bye, Matthew; Hansen, Doris; Ferreri, Christopher; Freeman, Ciara L; Afrough, Aimaz; Anderson, Larry D Jr; Dhakal, Binod; Dhanda, Devender; Gowda, Lohith; Hashmi, Hamza; Harrison, Melanie J; Kitali, Amani; Landau, Heather; Mirza, Abu-Sayeef; Patwardhan, Pallavi; Qazilbash, Muzaffar; Usmani, Saad; Patel, Krina; Nishihori, Taiga; Ganguly, Siddhartha; Pasquini, Marcelo C

Isatuximab for relapsed and/or refractory AL amyloidosis: results of a prospective phase 2 trial (SWOG S1702)

Isatuximab治疗复发和/或难治性AL淀粉样变性:一项前瞻性2期试验(SWOG S1702)的结果

Parker, Terri L; Rosenthal, Adam; Sanchorawala, Vaishali; Landau, Heather J; Campagnaro, Erica L; Kapoor, Prashant; Neparidze, Natalia; Girnius, Saulius; Hagen, Patrick; Scott, Emma C; Hoering, Antje; Durie, Brian G M; Orlowski, Robert Z

Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702

尿液无反应标准预测多发性骨髓瘤的无进展生存期:BMT CTN 0702 的事后分析

Banerjee, Rahul; Fritz, Amber R; Akhtar, Othman S; Freeman, Ciara L; Cowan, Andrew J; Shah, Nina; Landau, Heather J; Kumar, Shaji K; Vogl, Dan T; Efebera, Yvonne A; McCarthy, Philip L; Vesole, David H; Mendizabal, Adam; Krishnan, Amrita Y; Somlo, George; Stadtmauer, Edward A; Pasquini, Marcelo C

Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies

嵌合抗原受体T细胞疗法治疗血液系统恶性肿瘤后的体液疫苗反应

Einarsdottir, Sigrun; Lobaugh, Stephanie; Luan, Danny; Gomez-Llobell, Marina; Subramanian, Padmapriya; Devlin, Sean; Chung, David; Dahi, Parastoo B; Falchi, Lorenzo; Giralt, Sergio; Landau, Heather; Lesokhin, Alexander M; Lin, Richard; Lue, Jennifer; Mailankody, Sham; Palomba, M Lia; Park, Jae H; Salles, Gilles; Scordo, Michael; Escribano-Serrat, Silvia; Sanz, Jaime; Rejeski, Kai; Shouval, Roni; Usmani, Saad; Perales, Miguel-Angel; Shah, Gunjan; Shahid, Zainab

Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

达雷妥尤单抗耐药性对复发难治性多发性骨髓瘤CAR-T细胞疗法后临床结局的影响

Sebastian, Tara; Rajeeve, Sridevi; Farzana, Tasmin; Firestone, Ross; Jurgens, Eric; Miller, Kevin; Costa, Bruno Almeida; Lesokhin, Alexander; Tan, Carlyn Rose; Shah, Gunjan; Korde, Neha; Landau, Heather; Scordo, Michael; Hassoun, Hani; Maclachlan, Kylee; Shah, Urvi; Hultcrantz, Malin; Derkach, Andriy; Nemirovsky, David; Giralt, Sergio; Usmani, Saad; Mailankody, Sham; Hashmi, Hamza